ProtoKinetix’ 2nd Quarter Scientific Update

by Business Wire • 2016/07/14 • 0 Comments

ST. MARYS, W. Va.--(BUSINESS WIRE)--ProtoKinetix’ 2nd Quarter Scientific Update

← Inotek initiates phase 2 trial for fixed-dose combination of trabodenoson, latanoprost

Technavio Announces Top Five Vendors in the Global Semiconductor Laser Treatment Market until 2020 →